Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
914
NCT02864810
Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 4, 2016
Completion: Sep 9, 2017
NCT03112096
A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease
Start: May 17, 2017
Completion: Aug 31, 2018
NCT03546868
Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease
Phase: Phase 2
Start: Aug 14, 2018
Completion: Jan 11, 2019
NCT05334680
International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms
Phase: N/A
Role: Collaborator
Start: Jun 24, 2021
Completion: Dec 31, 2023
NCT06938347
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
Phase: Phase 3
Start: Nov 30, 2025
Completion: Jun 30, 2026